Theresa Werner is an Oncology physician affiliated with University of Utah. OpenAlex indexes 175 publications with 5,944 citations (h-index 34); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1950 Circle Of Hope
Clinic 2b
Salt Lake City, UT 841125550
Telephone
801-585-0100Provider last certified this registry record 17 Dec 2021.
Clinical trials
- The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
Sponsor: University of Utah
- BKM120 in Advanced, Metastatic, or Recurrent Endometrial Cancers
Sponsor: University of Utah
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 2019–2025 per NIH RePORTER. The latest:
- Clinical Protocol and Data Management
Utah State Higher Education System--University of Utah
FY2025$275,703P30CA042014
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024
Journal of the National Comprehensive Cancer Network
2024 - Cyclists’ perceived safety on intersections and roundabouts – A qualitative bicycle simulator study
Journal of Safety Research
2023 - NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
Journal of the National Comprehensive Cancer Network
2022 - Translational randomized phase II trial of cabozantinib in combination with nivolumab in advanced, recurrent, or metastatic endometrial cancer
Journal for ImmunoTherapy of Cancer
2022 - First-in-human phase 1/1b study to evaluate sitravatinib in patients with advanced solid tumors
Investigational New Drugs
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Frederick Welt, MD
University of Utah
Jennifer Majersik, MD
University of Utah
Richard Gurgel, MD
University of Utah
Fuad Shihab, MD
University of Utah
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”